The latest closing stock price for Alnylam Pharmaceuticals as of June 27, 2025 is 322.83.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $52,715 today, roughly 53 times their original investment - a 20.89% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 325.00 on June 24, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 326.03, which is 1% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 205.87, which is 36.2% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 264.03.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $52,715 today, roughly 53 times their original investment - a 20.89% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 325.00 on June 24, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 326.03, which is 1% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 205.87, which is 36.2% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 264.03.